Skip to main content
. 2019 Jan;25(1):10.18553/jmcp.2019.25.1.018. doi: 10.18553/jmcp.2019.25.1.018

Table 3.

Medicare Beneficiary Population and Prevalence

Population Prevalence
Total CMS population (2010-2011)a 53,765,609
CMS population, FFS (2010-2011)b 15,526,034
Diagnosed abusers, FFS (2010-2011) 204,052
Diagnosed abuser prevalence (2010-2011) 13.1 per 1,000 (1.3%)
Diagnosed abusers with disability (2010-2011) 155,386
Proportion of diagnosed abusers with disability 76.2%
At risk for abuse population, FFS (2010-2011) 1,822,937
At risk for abuse prevalence (2010-2011) 117.4 per 1,000 (11.7%)
Control with opioid use population (2010 2011)c 7,970,354
Control without opioid use population (2010-2011) 7,528,500
Total control populationd 15,498,854
Prevalence of opioid use (2010-2011) 514.3 per 1,000 (51.4%)
Prevalence of nonopioid use (2010-2011) 485.7 per 1,000 (48.6%)

aMedicare Beneficiary Summary File.

bDid not include patients who received Parts A and B through a Medicare Advantage plan.

cIncludes diagnosed abuse and at-risk abuse.

dOpioid use population + nonopioid use population.

CMS = Centers for Medicare & Medicaid Services; FFS = fee for service.